Bullish Case: Helium's +2.91% forecast and 78% higher bullish risk across tenors align with the Helium PDF's dominant mass at $18–19 (density 0.13) versus a thin market-implied tail. The $17–19 IV region is moderate (~65–75%), making upside calls into year-end catalysts (zovegalisib data, M&A chatter including Pfizer, Google's stake) comparatively cheap versus the inflated put tails the market overpays for.

Bearish Case: Term structure is in backwardation and puts traded 330% more call-side volume — heavy hedging demand. The RLAY surface shows extreme IV for strikes ≤14 (150–350%), pricing real crash tails, and the market PDF piles mass at $11–13. After a 196% two-year run, price is mean-reverting, -10.8% over 60 days, and any mixed readout, dilution, or SPY risk-off (SPY surface shows fat downside vol) can drag RLAY toward $15–17.

Potential Outcomes:

1. 35% — $17–19 base: Helium PDF mass at 18–19 holds; IV mean-reverts absent binary news.
2. 25% — $19–22 upside: positive data/partner catalyst; falsifiable via break+hold above ~$19.5.
3. 25% — $14–16: break+hold below $17.5 lifts put-tail IV further.
4. 10% — <$13: adverse readout or dilution; deep-put IV already signals this tail.
5. 5% — >$25 spike: buyout rumor; verify via 22–27 call IV/volume shifts.

October 24, 2026